Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOTHAM
2023-509610-11-00Phase 3Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxygen in Hamstring Injury, sponsored by Amsterdam University Medical Center. Primary endpoint: Time to return to play or full unrestricted duty. Planned start Oct 2024; status: authorised.
02
Drugs
oxygen
03
Conditions
Hamstring Injury
Beyond the preview
Go deeper on 2023-509610-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509610-11-00.